Neglected disease research and development: how much are we really spending

January 26, 2009

Please describe the reason for abuse:

Peer-Reviewed Paper, View Original
The need for new pharmaceutical tools to prevent and treat neglected diseases is widely accepted. The creation of a vaccine for HIV/AIDS, more... » More
PLoS Med. 2009 Feb 3; 6(2):e1000030
Mary Moran, Javier Guzman, Anne-laure Ropars, Alina Mcdonald, Nicole Jameson, Brenda Omune, Sam Ryan, Lindsey Wu

Belongs to:

Loading comments
  1. Hotez P, Molyneux DH, Fenwich A, Kumaresan J, Sachs SE (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1026.
  2. Toreele E, Usdin M, Chirac P (2004) A needs-based pharmaceutical R&D agenda for neglected diseases. World Health Organization: 12Available: Accessed 30 December 2008.
  3. IJsselmuiden C, de Haan S, Iacono SL, Kisia CN, Moomal H (2008) Alignment and harmonisation in health research: AHA study. Council for Health Research for Development: 29-39Available: Accessed 30 December 2008.
  4. Currat LJ, de Francisco A, Al-Tuwaijri S, Ghaffar A, Jupp S (2004) Progress in measuring the 10/90 gap. Global Forum for Health Research: 107-126Available: Accessed 30 December 2008.
  5. (2008) Sustaining the HIV prevention research agenda: Funding for research and development of HIV vaccines, microbicides, and other new prevention options 2000–2007: 1-38Available: Accessed 30 December 2008.
  6. Feuer C (2007) . Tuberculosis research and development: A critical analysis of funding trends, 2005–2006Treatment Action Group. New York.
  7. (2005) Malaria research & development: An assessment of global investment. Program for Appropriate Technology in Health: 1-53Available: Accessed 30 December 2008.
  8. (2001) Macroeconomics and health: Investing in health for economic development. Report of the Commission on Macroeconomics and Health: 89Available: Accessed 30 December 2008.
  9. (2008) Diseases covered by NTD departmentAvailable: Accessed 30 December 2008.
  10. (2008) Overview on diseasesAvailable: Accessed 30 December 2008.
  11. (2008) The seven most common NTDsAvailable: Accessed 30 December 2008.
  12. (2005) A new era of hope for the world's most neglected diseases. PLoS Med 2: e323doi:10.1371/journal.pmed.0020323.
  13. (2002) National Institutes of Health Fiscal Year 2002 Plan for HIV-Related Research USA 5–266.
  14. Anderson J, MacLean M, Davies C (1996) Malaria research—An audit of international activity. PRISM (Unit for Policy Research in Science and Medicine) UK Report 7: 1-96.
  15. (2007) IMF exchange rates databaseAvailable: Accessed 7 December 2007.
  16. (2007) Main science and technology indicators databaseAvailable: Accessed 7 December 2007.
  17. (2008) The global burden of disease: 2004 updateAvailable: Accessed 30 December 2008.
  18. Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A (2007) The malaria product pipeline: Planning for the future. The George Institute for International HealthAvailable: Accessed 30 December 2008.
Copyright 2013 © Mary Moran, Javier Guzman, Anne-laure Ropars, Alina Mcdonald, Nicole Jameson, Brenda Omune, Sam Ryan, Lindsey Wu. This pubcast is licensed under the terms of the Creative Commons Attribution License 3.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.